Skip to content
Search

Latest Stories

RPS endorses new RSHE Guidance highlighting pharmacists’ role in self-care

RPS endorses new RSHE Guidance highlighting pharmacists’ role in self-care

The RSHE consultation, focusing on the role of pharmacists in self-care, will be open for feedback until July 11

The Royal Pharmaceutical Society (RPS) has expressed its strong support for the Department of Education's consultation on revising the statutory guidance for Relationships, Sex, and Health Education (RSHE) and the proposal to increase awareness of the role pharmacists in the provision of self-care.


The Department of Education has announced revisions to the Relationships, Sex, and Health Education (RHSE) statutory guidance and is currently gathering feedback through an online survey.

Welcoming the proposal to educate pupils about self-care and the vital role of pharmacists in managing minor ailments under the health protection and prevention section of the guidance, the RPS expressed their support "to include acknowledgement of the critical role that pharmacists play in self-care."

The ongoing review aims to ensure that the guidance equips schools to deliver high-quality RSHE, addressing the needs of children and young people.

This statutory guidance from the Department for Education, rooted in sections 80A of the Education Act 2002 and 403 of the Education Act 1996, is integral to preparing students for adult life by fostering informed and ethical decisions regarding their wellbeing, health, and relationships.

Although, RPS is "not an expert in terms of Relationships and Sex education and Health education statutory guidance" and is "unable to comment in detail on the majority of the content", Tase Oputu, RPS England Board Chair, said:

"We welcome the addition of the fact that pupils should know how and when to self-care for minor ailments, and the role of pharmacists as knowledgeable healthcare professionals," she said in reference to the section on Health and Wellbeing.

"It is vital that people from a young age are taught about self-care and the fact they can approach their local pharmacist for advice on minor ailments and the use of medicines.

"Self-care supports individuals to develop, protect, maintain and improve their health, wellbeing or wellness.

"The development of Pharmacy First means pharmacists can now deal with a range of conditions that require antibiotic treatments and we would expect this to develop to include further conditions in the future."

Within the the guidance, the health protection and prevention section emphasises the importance of pharmacists in areas pertaining minor ailments and navigating the healthcare system.

The guidance will review the results of the consultation, which is open until Thursday, July 11.

Additionally, the curriculum will cover the benefits of regular self-examination and screening, immunisation, and the significance of healthy behaviours before and during pregnancy.

Moreover, it will highlight "what a GP is, when to use A&E / minor injuries, accessing sexual health and family planning clinics, the role of local pharmacies."

Subjected to Ofsted inspections, health education is mandatory in all schools except, independent ones, to ensure schools provide a well-rounded and balanced curriculum. 

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less